FMS vs THC
Fresenius Medical Care AG and Tenet Healthcare Corp., side by side — 6 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | FMS | THC |
|---|---|---|
| Revenue | $14.6B | $21.3B |
| Net income | $1.1B | $2.4B |
| Gross margin | 32.4% | · |
| Net margin | 8.6% | 11.1% |
| Return on equity | 12.2% | · |
| Diluted EPS | $3.65 | $15.49 |
| Dividend / share | · | · |
| Payout ratio | 26.7% | · |
| Free cash flow | $1.3B | $2.5B |
| Equity | $9.2B | $4.2B |
| Net debt / equity | 0.78× | 2.42× |
| Current ratio | 1.77× | 1.76× |
| Revenue CAGR 5y | 6.6% | 3.9% |
| Profit CAGR 5y | 6.3% | 25.2% |
THC bills 1.5× the revenue of FMS, and keeps more of each dollar of revenue as profit (11.1% against 8.6%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
6 years side by side
| Fiscal year | FMS | THC |
|---|---|---|
| FY2013 | $14.6B | $12.1B |
| FY2012 | $13.8B | $9.9B |
| FY2011 | $12.6B | $8.7B |
| FY2010 | $11.8B | $8.3B |
| FY2009 | $11.2B | $8.3B |
| FY2008 | $10.6B | $8.6B |
Bottom line
| Fiscal year | FMS | THC |
|---|---|---|
| FY2013 | $1.1B | $-104.0M |
| FY2012 | $1.2B | $133.0M |
| FY2011 | $1.1B | $94.0M |
| FY2010 | $978.5M | $1.2B |
| FY2009 | $891.1M | $197.0M |
| FY2008 | $817.6M | $25.0M |
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2013 | +$2,550,727,000 | FMS |
| FY2012 | +$3,896,282,000 | FMS |
| FY2011 | +$3,916,515,000 | FMS |
| FY2010 | +$3,579,194,000 | FMS |
| FY2009 | +$2,929,477,000 | FMS |
| FY2008 | +$2,027,323,000 | FMS |
FMS has reported the higher revenue in every one of these 6 fiscal years. The gap has widened since the earliest year compared.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2013 | +9.5 pp | FMS |
| FY2012 | +8.3 pp | FMS |
| FY2011 | +8.3 pp | FMS |
| FY2010 | −4.9 pp | THC |
| FY2009 | +6.2 pp | FMS |
| FY2008 | +7.7 pp | FMS |
The higher net margin has changed hands between FMS and THC over this period.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
THC's net margin has been more volatile than FMS's over the 6 comparable fiscal years — 5.0 percentage points of standard deviation against 0.5.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between FMS and THC over these 6 fiscal years — FMS led in 5 and THC in 1.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
THC's return on equity has been more volatile than FMS's over the 3 comparable fiscal years — 31.2 percentage points of standard deviation against 0.1.
3 of 7 comparable fiscal years — a year missing data on either side is not counted.
Year by year
THC led in return on equity in every one of the 3 comparable fiscal years — a structural lead, not a recent swing.
3 of 7 comparable fiscal years — a year missing data on either side is not counted.